From the Department of Nuclear Medicine, Kuwait Cancer Control Center, Khaitan, Kuwait.
Jack Brignall PET/CT Centre, Castle Hill Hosptial, Cottingham, United Kingdom.
Clin Nucl Med. 2021 Aug 1;46(8):661-663. doi: 10.1097/RLU.0000000000003515.
68Ga-PSMA is an excellent radiotracer for both staging and detection of recurrence in prostate cancer, but it can also be useful in other solid tumors due to tumor-associated angiogenic factors and endothelial cell sprouting. We report a case of an 82-year-old man with hepatocellular carcinoma who presented with rising tumor marker but stable CT findings 6 months after transarterial chemoembolization. 68Ga-PSMA PET/CT showed high PSMA-expressing hyperneovascular hepatic lesions (primary tumor), additional multifocal hepatic lesions, and with unexpected multiple bone metastases. 68Ga-PSMA expression in hepatocellular carcinoma can influence patient management and potentially guide radionuclide legend therapy.
68Ga-PSMA 是一种出色的放射性示踪剂,可用于前列腺癌的分期和复发检测,但由于肿瘤相关的血管生成因子和内皮细胞发芽,它也可用于其他实体瘤。我们报告了一例 82 岁男性肝细胞癌患者,在经动脉化疗栓塞治疗后 6 个月,肿瘤标志物升高但 CT 检查结果稳定。68Ga-PSMA PET/CT 显示高 PSMA 表达的富血管性肝病变(原发性肿瘤),另外还有多个局灶性肝病变,以及意外的多处骨转移。肝细胞癌中 68Ga-PSMA 的表达可以影响患者的管理,并可能指导放射性核素标记治疗。